Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03348826

Study of Sodium Bicarbonate in Restoring Blocked Catheters

Sodium Bicarbonate Injections for Restoration of Flow in a Central Venous Catheter (CVC/Hickman Catheter) or Peripherally Inserted Central Venous Catheter (PICC)

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a study looking at the use of sodium bicarbonate to restore the flow of blocked central line devices in patients with blood cancers. Central line devices uses thin tubes that are placed into a vein in the body to give medicines, fluids, nutrients, blood products, etc. Sometimes, the lines become blocked. The standard procedure to get the line working again is to use alteplase, a protein that dissolves blood clots. While blood clotting is one cause of a blocked line, other reasons included the formation of calcium deposits. Sodium bicarbonate is routinely used in the treatment of patients receiving chemotherapy. Sodium bicarbonate is a liquid drug which is capable of dissolving protein and calcium deposits. This study will compare whether sodium bicarbonate works just as well as alteplase to recover the function of a blocked line.

Conditions

Interventions

TypeNameDescription
DRUGSodium Bicarbonate 8.4% Solution for Injection3 mL injection into line with up to 2 injections administered
DRUGAlteplase Injectable Solution2 mL injection into line with up to 2 injections administered

Timeline

Start date
2020-06-01
Primary completion
2020-09-01
Completion
2021-09-02
First posted
2017-11-21
Last updated
2020-09-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03348826. Inclusion in this directory is not an endorsement.